![]() |
市場調查報告書
商品編碼
1953820
傷口護理器材市場-全球產業規模、佔有率、趨勢、機會、預測:按傷口類型、產品、最終用戶、地區和競爭對手分類,2021-2031年Wound Therapy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Wound Type, By Product, By End-User, By Region & Competition, 2021-2031F |
||||||
全球傷口護理市場預計將從 2025 年的 49.6 億美元成長到 2031 年的 68.9 億美元,複合年成長率為 5.63%。
這些設備包括負壓治療系統和高壓氧氣療法艙,它們是專門用於促進急性和慢性損傷的治療和癒合的設備。推動市場成長的主要因素是全球範圍內與文明病(例如肥胖和糖尿病)的增加,這些疾病顯著提高了複雜性潰瘍的發生率。此外,全球人口老化也是推動市場需求的因素之一,因為老年患者的生理癒合能力往往下降,更容易發生褥瘡等壓力性損傷。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 49.6億美元 |
| 市場規模:2031年 | 68.9億美元 |
| 複合年成長率:2026-2031年 | 5.63% |
| 成長最快的細分市場 | 負壓傷口治療(NPWT) |
| 最大的市場 | 北美洲 |
然而,購置先進治療設備的成本極為高昂,嚴重阻礙了市場發展。儘管對專科護理的需求日益成長,但在經濟敏感地區,此類設備的普及卻受到限制。儘管需要此類治療的患者人數不斷增加,但這種經濟障礙仍然是一大阻礙。根據國際糖尿病聯盟(IDF)預測,到2024年,全球將有約5.89億成年人患有糖尿病,而糖尿病與慢性傷口的發生密切相關。這項數據凸顯了開發價格合理的治療性介入以減輕醫療基礎設施日益沉重負擔的迫切需求。
文明病和慢性病在全球範圍內的日益流行,為全球傷口護理器材市場奠定了至關重要的基礎。糖尿病和肥胖等代謝紊亂會顯著損害生理癒合機制,增加慢性皮膚損傷和難治性潰瘍的發生率,而這些疾病需要更高階的治療。隨著這些疾病的日益普遍,需要長期創傷護理的患者數量也在增加,因此亟需引入生物活性器材和負壓傷口治療技術,以預防截肢和感染。根據世界肥胖聯盟於2024年3月發布的《2024年世界肥胖地圖集》,目前全球有超過10億人患有肥胖症,這與壓瘡和靜脈潰瘍的風險增加直接相關。如此龐大的患者群體推動了對用於治療複雜難癒合傷口的器械的持續需求。
同時,燒燙傷和創傷病例的不斷增加,使得有效的傷口管理和閉合系統變得特別重要。嚴重的身體創傷和燒燙傷需要長期、即時的治療支持以恢復組織完整性,這使得專用醫療設備在急診環境中至關重要。正如2024年3月發表在《燒傷》(Burns)雜誌上的研究報告《全球燒燙傷負擔及其與社會經濟發展的關係》所指出的,全球嚴重燒燙傷的患病人數估計為1299萬,凸顯了急性創傷給醫療保健提供者帶來的巨大負擔。這種迫切的需求正在推動市場顯著成長,醫療保健系統正在採用先進的管理解決方案。例如,史密斯醫療(Smith+Nephew)在2024年2月發布的2023年第四季度和全年財務業績報告中顯示,其先進傷口管理業務的核心收入成長了6.4%,這表明這些技術在全球市場得到了持續應用。
先進醫療器材的高昂採集費用嚴重阻礙了全球傷口護理器材市場的成長。許多醫療機構,尤其是公立醫療系統和發展中地區的醫療機構,預算捉襟見肘,難以負擔負壓傷口治療系統等昂貴技術。因此,這些專業器材的應用往往僅限於私立醫療機構和富裕的都市區。這種經濟差距迫使價格敏感的市場依賴更經濟的傳統替代方案,抑制了製造商的潛在利潤,並延緩了先進解決方案的普及。
鑑於需要有效傷口管理的患者數量龐大,此經濟障礙尤其具有限制性。根據2024年傷口、造口和失禁護理(WOCN)數據,光是在美國,下肢動脈疾病患者就估計達650萬人。此類疾病的高發生率表明迫切需要有效的治療方法。然而,先進醫療設備所需的高額資本投入阻礙了其在不斷成長的患者群體中的普及,直接限制了市場成長。
一次性負壓傷口治療 (NPWT) 系統的出現,從根本上改變了市場格局,為傳統的、資本密集型設備提供了一種便攜且經濟高效的替代方案。與笨重的罐式裝置不同,這些緊湊的一次性設備使患者能夠在居家照護環境中接受持續治療,從而顯著提高患者的活動能力並縮短住院時間。這種轉變消除了維護和購買昂貴硬體的需求,從而減輕了高級創傷護理相關的經濟負擔。主要產業領導者的財務表現也印證了這些產品的快速普及。例如,在2024年2月發布的2023年第四季度和全年收益報告中,史密斯醫療 (Smith+Nephew) 報告稱,其高級傷口護理設備部門的基本收入實現了兩位數的成長,這主要得益於對一次性 PICO 負壓傷口治療系統的強勁需求。
同時,人工智慧驅動的自動化傷口評估技術的整合正在革新臨床工作流程,以精準的數位分析取代主觀的人工評估。人工智慧平台現在利用智慧型手機的標準相機捕捉傷口影像,並自動計算組織成分和表面積,從而高精度地監測癒合過程。這種技術協同作用透過促進標準化記錄和早期發現併發症,改善了臨床決策,在慢性病管理中發揮至關重要的作用。目前,該領域正投入大量資金以增強這些數位化能力。正如2024年1月發布的公告「Swift Medical融資800萬美元推進人工智慧驅動的創傷護理」中所述,Swift Medical成功資金籌措了800萬美元,用於加速其人工智慧平台的開發。該公司的平台目前已部署在4,000多家醫療機構。
The Global Wound Therapy Devices Market is projected to expand from USD 4.96 Billion in 2025 to USD 6.89 Billion by 2031, reflecting a compound annual growth rate of 5.63%. These devices, which include negative pressure systems and hyperbaric chambers, are specialized instruments engineered to expedite the management and healing of both acute and chronic injuries. A primary catalyst for this market growth is the rising global incidence of lifestyle-related conditions, such as obesity and diabetes, which drastically increase the occurrence of complex ulcers. Furthermore, the aging global demographic continues to fuel demand, as geriatric patients often experience diminished physiological healing capacities and are more prone to pressure injuries.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 4.96 Billion |
| Market Size 2031 | USD 6.89 Billion |
| CAGR 2026-2031 | 5.63% |
| Fastest Growing Segment | Negative Pressure Wound Therapy (NPWT) |
| Largest Market | North America |
However, market progression is notably hindered by the substantial acquisition costs of advanced therapeutic equipment, restricting their adoption in economically sensitive regions despite the expanding need for specialized care. This financial obstacle remains a significant hurdle even as the patient population requiring such treatment grows. According to the International Diabetes Federation, approximately 589 million adults worldwide were living with diabetes in 2024, a condition heavily linked to chronic wound prevalence. This statistic highlights the critical requirement for affordable therapeutic interventions to alleviate the mounting pressure on healthcare infrastructure.
Market Driver
The surging global prevalence of lifestyle-related and chronic diseases establishes a crucial basis for the Global Wound Therapy Devices Market. Metabolic disorders like diabetes and obesity significantly impair physiological healing mechanisms, resulting in a higher incidence of chronic skin defects and hard-to-heal ulcers that demand sophisticated intervention. As these conditions become more ubiquitous, the volume of patients necessitating long-term wound care grows, requiring the deployment of bioactive devices and negative pressure wound therapy to avert amputation and infection. According to the 'World Obesity Atlas 2024' released by the World Obesity Federation in March 2024, over one billion individuals globally are currently living with obesity, a factor directly linked to increased vulnerability to pressure injuries and venous leg ulcers. This immense patient demographic fuels a persistent need for devices designed to manage complex, non-healing wounds.
Simultaneously, the increasing frequency of burn cases and traumatic injuries necessitates effective systems for wound management and closure. Severe physical trauma and burns demand prolonged, immediate therapeutic assistance to reestablish tissue integrity, rendering specialized devices indispensable in acute care environments. As noted in the study 'Global burden of burns and its association with socio-economic development status' published in the journal Burns in March 2024, the global prevalence of severe burn injuries was estimated at 12.99 million, emphasizing the significant load acute injuries place on healthcare providers. This urgent demand translates into measurable market growth as health systems procure advanced management solutions. For example, Smith+Nephew reported in their 'Fourth Quarter and Full Year 2023 Results' in February 2024 that their Advanced Wound Management unit achieved 6.4% underlying revenue growth, indicating sustained uptake of these technologies in global markets.
Market Challenge
The substantial acquisition expenses linked to advanced therapeutic equipment pose a significant barrier to the growth of the global wound therapy devices market. Numerous healthcare institutions, particularly those within publicly funded systems and developing regions, function under tight budget limitations that restrict their capacity to procure costly technologies like negative pressure wound therapy systems. As a result, the deployment of these specialized devices is frequently limited to private facilities or wealthy urban centers. This economic disparity necessitates a dependence on traditional, less expensive alternatives in price-sensitive markets, effectively curtailing the potential revenue for manufacturers and retarding the broader penetration of sophisticated solutions.
This financial hurdle is especially restrictive given the vast patient population in need of effective wound management. According to data from the Wound, Ostomy, and Continence Nurses Society in 2024, lower extremity arterial disease was estimated to impact 6.5 million individuals in the United States alone. The high incidence of such conditions suggests an urgent requirement for effective healing treatments. Nevertheless, the prohibitive capital investment needed for advanced devices precludes their widespread adoption for this growing patient group, directly impeding the market's growth trajectory.
Market Trends
The emergence of Single-Use and Disposable Negative Pressure Wound Therapy (NPWT) Systems is fundamentally transforming the market by providing portable, cost-efficient alternatives to conventional, capital-heavy equipment. In contrast to cumbersome canister-based units, these compact disposable devices allow patients to undergo continuous therapy within home care environments, greatly improving mobility and decreasing the duration of hospital stays. This transition mitigates the economic challenges of advanced wound care by removing the necessity for costly hardware maintenance and purchases. The swift adoption of these products is evident in the financial results of major industry leaders; for instance, Smith+Nephew reported in their 'Fourth Quarter and Full Year 2023 Results' in February 2024 that their Advanced Wound Devices division realized double-digit underlying revenue growth, largely fueled by strong demand for their single-use PICO Negative Pressure Wound Therapy System.
Concurrently, the integration of Artificial Intelligence for Automated Wound Assessment is revolutionizing clinical workflows by substituting subjective manual evaluations with accurate digital analysis. AI-driven platforms now leverage standard smartphone cameras to capture wound images, automatically computing tissue composition and surface area to monitor healing progress with high precision. This technological synergy improves clinical decision-making by standardizing documentation and facilitating the early identification of complications, which is essential for chronic condition management. The sector is witnessing substantial capital investment to bolster these digital capabilities. As announced in 'Swift Medical Secures $8M to Power AI-Driven Wound Care' in January 2024, Swift Medical successfully raised $8 million specifically to expedite the development of its AI platform, which currently serves more than 4,000 healthcare facilities.
Report Scope
In this report, the Global Wound Therapy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Wound Therapy Devices Market.
Global Wound Therapy Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: